Asymmetric dimethylarginine (ADMA) plays a crucial role in endothelial function and maybe a link for the known interaction of periodontitis and coronary heart disease (CHD). In this pilot study, we compared the impact of gingival health, periodontitis (CP), CHD or of both diseases (CP+CHD) on salivary and serum ADMA levels.
Evaluation of salivary and serum asymmetric dimethylarginine (ADMA) levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk
Isola, Gaetano
Primo
Writing – Review & Editing
;Ientile, RiccardoPenultimo
;
2020-01-01
Abstract
Asymmetric dimethylarginine (ADMA) plays a crucial role in endothelial function and maybe a link for the known interaction of periodontitis and coronary heart disease (CHD). In this pilot study, we compared the impact of gingival health, periodontitis (CP), CHD or of both diseases (CP+CHD) on salivary and serum ADMA levels.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Isola et al 2020 JOP.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Dimensione
518.12 kB
Formato
Adobe PDF
|
518.12 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
